BioSpace News Archive

Halozyme forecasts 25 to 30 percent royalty revenue growth in 2018 and potential for royalty revenue to reach nearly $1B in 2027 based on the current and expected momentum of partners coformulating products with its ENHANZE technology.

WuXi AppTec and Mayo Clinic announced today a joint venture to co-develop and deliver clinical diagnostic services in China.

The agreement enables Exploragen to launch its SlumberType DNA app on the SleepScore ecosystem.

Iain will succeed Dr. David Plans, Co-Founder and Chief Science Officer, who has successfully led the development of BioBeats transformational digital health app, Hear and Now, as well as being instrumental in closing five funding rounds and building solid commercial partnerships with the likes of global insurance and financial powerhouses AXA and BNP Paribas.

Patients in the study were treated at the two centers between December 2008 and October 2016.

Dr. Leach brings to the company over 13 years of experience in the biopharmaceutical industry.

In an effort to help veterans excel in civilian life, Bayer and VETTED today unveiled a new partnership in which Bayer will serve as title sponsor of VAMP at the University of Texas and Texas A&M University.

NanoTemper Technologies launched its latest system, Tycho NT.6, at the PepTalk conference in San Diego.

Total revenue for 2017 expected to be approximately $52.5 million, representing an increase of 7% over 2016

The lawsuit alleges that Quantel products infringe U.S. Patent No. 7,771,417, that Quantel breached an earlier agreement between the parties, and that Quantel has infringed Iridex’s MicroPulse trademark, Registration No. 4550188 on the principal register.